Kou Kan Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 135.58%
- Profit Growth -828.16%
- Ebitda -33.03%
- Net Worth -157.90%
- Total Assets 23.23%
About Kou Kan Pharmaceutical
Kou Kan Pharmaceutical Private Limited (KKPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2018 (Six years and five months 20 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnamurari Rai and Marutikumar Rai serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH2018PTC313639
- Company No.
313639
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2018
- Date of AGM
31 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Kou Kan Pharmaceutical Private Limited offer?
Kou Kan Pharmaceutical Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules.
Who are the key members and board of directors at Kou Kan Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamurari Rai  | Additional Director | 01-Jun-2023 | Current |
| Marutikumar Rai | Director | 06-Sep-2018 | Current |
Financial Performance of Kou Kan Pharmaceutical.
Kou Kan Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 135.58% increase. The company also saw a substantial fall in profitability, with a 828.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 157.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kou Kan Pharmaceutical?
Unlock access to Kou Kan Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kou Kan Pharmaceutical?
Unlock and access historical data on people associated with Kou Kan Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kou Kan Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kou Kan Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
